🔴 Wave Life Sciences is trading 7.4% down today after reporting a wider-than-expected Q2 loss and revenue miss

Wave Life Sciences is trading 7.4% down at $5.38 after reporting a wider-than-expected second quarter loss and revenue that missed analyst estimates.

• The company reported a sharp drop in revenue to $2.3 million and a net loss of $69.4 million for the quarter, weighing on investor sentiment.
• Despite the financial results, management highlighted progress in key clinical programs and a cash runway projected to last into the third quarter of 2028.